PubMed · 1997 · 65 citations · 20 references
MedicineNeurosciencePharmacologyMolecular ImagingNeurochemistryNeuropharmacologyBrain ImagingDopaminergic PharmacologyPositron Emission TomographyDopamine Receptor ImagingFluorine-18 Fluorodeoxyglucose Positron Emission TomographyFluorodopa PetImage Contrast EvaluationImage Contrast MechanismsPet TracersTracer TechniquesVisual Inspection
UNLABELLED: Fluorinated m-tyrosine analogs were evaluated as PET imaging agents and compared with 6-fluoroDOPA in the visualization of dopamine nerve terminals. METHODS: The three m-tyrosine analogs, 6-[18F]fluoro-L-m-tyrosine (6-FMT), 2-[18F]fluoro-L-m-tyrosine (2-FMT) and 6-[18F]fluoro-fluoromethylene-DL-m-tyrosine (6-F-FMMT), were prepared via electrophilic radiofluorination using [18F]acetylhypofluorite. These three analogs, as well as 6-[18F]fluoro-L-DOPA (6-FD), were injected into sets of rhesus monkeys, and serial PET images were acquired. Plasma samples were collected at different times after tracer administration, and metabolite analyses were done using high-performance liquid chromatography (HPLC). RESULTS: Visual inspection of the PET images obtained using these four tracers showed that the best image contrast was obtained with 6-FMT. Patlak analysis with a reference tissue input function yielded a mean uptake rate constant for 6-FMT of 0.019 min-1, a value twice those for the other tracers including 6-FD. CONCLUSION: These results demonstrate the superiority of 6-[18F]FMT in visualizing dopamine terminals in the rhesus monkey brain and suggest that 6-[18F]FMT is the tracer of choice in the assessment of dopamine metabolism in the living human brain.
20
Dopamine visualized in the basal ganglia of living man
E.S. Garnett, G. Firnau, Claude Nahmias · Nature · 1983 · 644 citations